6.4M Seniors Hit by 3-Week Prior Auth Delays in Medicare AI Pilot
The WISeR pilot, using AI for prior authorization in traditional Medicare, is causing weeks-long delays for patients in Washington state, prompting Senator Maria Cantwell to say it overrides doctors and denies care. The program affects 6.4 million beneficiaries across six states.
Key Takeaways
- The WISeR pilot, using AI for prior authorization in traditional Medicare, is causing weeks-long delays for patients in Washington state, prompting Senator Maria Cantwell to say it overrides doctors and denies care.
- The program affects 6.4 million beneficiaries across six states.
Mentioned
Key Intelligence
Key Facts
- 1The WISeR pilot began in January 2026, covering 6.4 million traditional Medicare beneficiaries in six states (NJ, OH, OK, TX, AZ, WA).
- 2AI-assisted prior authorization reviews apply to epidural steroid injections, spinal stenosis and knee osteoarthritis treatments, and nerve stimulation for tremor/Parkinson's.
- 3In Washington state, authorization decisions now take up to three weeks, up from a few days; procedure waiting times are significantly longer, per Senator Maria Cantwell.
- 4CMS Administrator Mehmet Oz stated the pilot aims to 'root out waste in Original Medicare' using enhanced technologies including AI.
- 5The KFF health policy organization notes prior authorization can cause administrative burdens, care delays, and denial of necessary services.
- 6The six-year pilot could serve as a model for national expansion, but early backlash threatens its viability.
Who's Affected
Per Sen. Cantwell's report, WISeR delays
Analysis
For healthcare providers and patients, the introduction of prior authorization into traditional Medicare—historically free of such hurdles—marks a seismic shift. The WISeR pilot's early results, with Washington seniors waiting up to three weeks for AI-driven decisions, underscore the tension between cost containment and timely access to care. As the program expands to more beneficiaries, clinicians worry that an opaque algorithmic gatekeeper may undermine medical judgment and harm patient outcomes.
In a historic shift for Original Medicare, the Centers for Medicare & Medicaid Services (CMS) launched the Wasteful and Inappropriate Service Reduction (WISeR) pilot in January 2026, introducing prior authorization—and artificial intelligence—to millions of beneficiaries who never before faced such hurdles. For decades, traditional Medicare largely sidestepped the prior authorization burdens that have angered patients and providers in Medicare Advantage plans. The WISeR model, however, now requires pre-approval for a slate of common procedures across six states, including epidural steroid injections, treatments for spinal stenosis and knee osteoarthritis, and nerve stimulation for tremors and Parkinson’s disease. With approximately 6.4 million beneficiaries affected in New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington, the pilot is a six-year experiment designed to slash “crushing fraud, waste, and abuse,” in the words of CMS Administrator Mehmet Oz. The agency is contracting with private companies that use “enhanced technologies, including artificial intelligence” to adjudicate requests—a move intended to modernize oversight but one that immediately ignited controversy.
A report from Senator Maria Cantwell (D-Wash.) reveals that seniors in her state are now waiting up to three weeks for authorization decisions that once took days, with procedure backlogs stretching even longer.
Barely six months in, the rocky start that critics predicted is materializing. A report from Senator Maria Cantwell (D-Wash.) reveals that seniors in her state are now waiting up to three weeks for authorization decisions that once took days, with procedure backlogs stretching even longer. “For Washington’s seniors, WISeR is overriding doctors to delay care and deny treatment,” she stated, echoing the very frustrations that have plagued Medicare Advantage for years. The KFF health policy organization has long cautioned that prior authorization can lead to administrative snarls, patient delays, and denials of medically necessary services—and those predictions are now being borne out in the traditional program. These delays are not merely inconvenient; they risk progression of degenerative conditions and unnecessary suffering for patients with chronic pain or neurological disorders.
The AI component adds a layer of opacity and unease. While CMS has framed the use of technology as a tool for efficiency, providers and patients have no visibility into how the algorithms make decisions. The private contractors remain unnamed, and there is no publicly available information on the models’ accuracy, bias, or error rates. For a pilot that could pave the way for a nationwide expansion, the lack of transparency raises serious governance questions. AI-driven healthcare decisions are already under intense scrutiny; earlier setbacks like the IBM Watson Health debacle loom large, and the WISeR pilot risks reinforcing skepticism if it cannot demonstrate fairness and reliability.
The stakes extend beyond patient care. A botched rollout could chill congressional appetite for further AI integration in Medicare, hindering automation that could genuinely reduce fraud and administrative waste if implemented thoughtfully. Conversely, if CMS can iron out the early kinks—improving review speeds, publishing algorithm performance data, and establishing clinician appeal pathways—the pilot might eventually serve as a case study for responsible AI in public health insurance. The six-year timeline gives the agency room to iterate, but the political pressure from lawmakers like Cantwell may accelerate demands for a pause or redesign.
What to Watch
Marketwise, the pilot opens a significant new revenue opportunity for health-tech firms specializing in utilization management software and AI decision support, but the current backlash could also taint their reputation if delays and denials are attributed to unaccountable black boxes. Investors and innovators watching the space understand that the pilot’s outcome will heavily influence future procurement of AI tools by CMS.
Looking ahead, the WISeR pilot is a real-time stress test of whether AI can arbitrate complex medical decisions at scale without sacrificing patient trust or timely access. The coming months will likely see more data from other pilot states, potentially confirming or contesting Washington’s experience. If the trend of delays persists, expect hearings, GAO audits, or legislative action. Either way, the experiment underscores an unavoidable lesson: deploying AI in healthcare gatekeeping requires far more than a competent model—it demands robust human oversight, transparency, and a relentless focus on patient outcomes.
Cite This Page
"6.4M Seniors Hit by 3-Week Prior Auth Delays in Medicare AI Pilot." Healthcare Intelligence Brief, June 22, 2026. https://gethealthbrief.com/story/medicare-prior-auth-ai-pilot-health-delays
How we covered this story
Every story in our healthcare coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.
Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the healthcare space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.
Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.
| Signal on this page | What it tells you |
|---|---|
| Verified by N sources | Independent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly. |
| Impact score (1-10) | Regulatory + financial + operational weight. 8+ signals an experienced-operator action item. |
| Sentiment | Five-tier classification trained on labeled healthcare-specific corpora. |
| Timeline | Where applicable, the related-events sequence that contextualizes today's development. |